Compare Sana Biotechnology Inc (SANA) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Western Alliance Bancorporation — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Western Alliance Bancorporation trades at $79.8 (market cap $8.84B). The key difference: Western Alliance Bancorporation is far larger — about 10.1× Sana Biotechnology Inc's market cap, and Western Alliance Bancorporation pays a 2.07% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | WAL | |
|---|---|---|
Market Cap | $873.84M | $8.84B |
Sector | Health | Financials |
52-Week High | $5.92 | $96.08 |
52-Week Low | $2.68 | $66.70 |
Enterprise Value | $848.03M | — |
Dividend Yield | — | 2.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
